Clinically relevant potential drug-drug interactions in intensive care patients: a large retrospective observational multicenter study

Autor: Bakker, T., Abu-Hanna, A., Dongelmans, D.A., Vermeijden, W.J., Bosman, R.J., Lange, D.W. de, Klopotowska, J.E., Keizer, N.F. de, Hendriks, S., Cate, J. ten, Schutte, P.F., Balen, D. van, Duyvendak, M., Karakus, A., Sigtermans, M., Kuck, E.M., Hunfeld, N.G.M., Sijs, H. van der, Feiter, P.W. de, Wils, E.J., Spronk, P.E., Kan, H.J.M. van, Steen, M.S. van der, Purmer, I.M., Bosma, B.E., Kieft, H., Marum, R.J. van, Jonge, E. de, Beishuizen, A., Movig, K., Mulder, F., Franssen, E.J.F., Bergh, W.M. van den, Bult, W., Hoeksema, M., Wesselink, E., SIMPLIFY Study Grp

Publikováno v: Journal of Critical Care, 62, 124-130. W B SAUNDERS CO-ELSEVIER INC
Journal of Critical Care, 62, 124-130. Elsevier BV
Journal of critical care, 62, 124-130. Elsevier BV
on behalf of the SIMPLIFY study group 2021, ' Clinically relevant potential drug-drug interactions in intensive care patients : A large retrospective observational multicenter study ', Journal of Critical Care, vol. 62, pp. 124-130 . https://doi.org/10.1016/j.jcrc.2020.11.020
Journal of Critical Care, 62, 124-130. Elsevier

Purpose: Potential drug-drug interactions (pDDIs) may harm patients admitted to the Intensive Care Unit (ICU). Due to the patient's critical condition and continuous monitoring on the ICU, not all pDDIs are clinically relevant. Clinical decision supp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6f8c02370353004a00cf7b3fff545e
http://hdl.handle.net/1887/3278261